Gene therapy aims to heal bladder lesions and ease chronic pain
NCT ID NCT07459790
First seen Mar 23, 2026 · Last updated May 16, 2026 · Updated 8 times
Summary
This study tests a gene therapy called Neovasculgen for people with a painful bladder condition that includes Hunner's lesions. The goal is to reduce scarring and prevent the bladder from shrinking after standard treatment. About 180 women aged 18 to 65 will receive either the drug or a placebo, and doctors will check their symptoms and bladder health for one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER PAIN SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Botkin Hospital
RECRUITINGMoscow, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.